SUMMARY
INTRODUCTION
There are three distinct serotypes of poliovirus that can be distinguished from each other in neutralization tests using polyclonal antisera. Individual clinical poliovirus isolates can be easily classified into one of the three serotypes using unabsorbed antisera. The poliovirus strains used in vaccines were isolated several decades ago but still appear to induce antibodies that protect well against the poliovirus strains that are prevalent today. This would suggest that the antigenic structure of polioviruses is relatively stable. In contrast, it has been shown by oligonucleotide fingerprinting (Nottay et al., 1981 ; Minor et al., 1982) that the genome of polioviruses (like that of other RNA viruses) can vary remarkably during replication in vivo.
At least three separate antigenic sites are known to be involved in neutralization of polioviruses. Regions of the three major structural proteins (VP1, 2 and 3) have been identified as antigenic sites and designated sites 1, 2 and 3 (Minor et al., 1985) . These sites have also been 0000-8308 © 1988 SGM mapped on the three-dimensional structure of virions . Site 1 includes a region of 12 amino acids on VP1 from residues 89 to 100, site 2 includes residues 220 to 222 on VP1 and 164 to 172 on VP2 and site 3 includes residues 286 to 290 on VP1 and 58 to 60 on VP3. For type 3 polioviruses, site l is immunodominant in mice (Icenogle er al., 1986) and in human recipients of the inactivated poliovirus vaccine (IPV) (Roivainen & Hovi, 1987) . It is also relatively stable among independent isolates of type 3 polioviruses .
A limited outbreak of poliomyelitis occurred in Finland in 1984 to 1985 after 20 years without a single case and without documented poliovirus circulation in the population (Hovi et al., 1986) . Before this outbreak only IPV and not live attenuated oral poliovaccine had been used in Finland for general immunization. The epidemic wild-type type 3 poliovirus was isolated from most of the 10 clinical cases and also from about l 5 ~ of healthy persons tested and all over the country from sewage. The antigenic properties of the P3/Finland/84 strains differed markedly from most type 3 polioviruses characterized previously (Magrath et al., 1986) . The genome of a representative strain was completely sequenced and showed remarkable differences from the previously sequenced type 3 strains (Hughes et al., 1986) . Furthermore, striking antigenic differences were found between individual isolates during the outbreak and an antigenic drift was shown in sequential specimens from some persons . Antigenic variation of a poliovirus type 3 vaccine strain (Sabin 3) during replication in a vaccine recipient (in the U.K.) has also been described .
In this paper we report an antigenic characterization of a total of 128 strains from human specimens and 45 strains isolated from sewage. Extensive variation was observed with both site 1-and site 2-specific monoclonal antibodies (MAbs) and by demonstrating amino acid substitutions in antigenic site 1.
METHODS
Virus strains. The 128 clinical strains analysed were isolated in cell cultures from faecal specimens of patients with poliomyelitis, healthy contacts of the patients or other healthy persons, and identified as poliovirus type 3 by neutralization with type-specific hyperimmune rabbit sera . Before antigenic analysis the strains were passaged twice in Vero cells at low multiplicity.
Microtitre endpoint dilution method. In order to separate putative variants present in the concentrated sewage specimens (Pfyry et al., 1988) we used, instead of the classical plaque purification, a less tedious method similar to the endpoint dilution method of cloning hyridoma cells. Several dilutions of virus specimens were distributed in microtitre plates (Nunc), one or two 96-well plates per dilution, and 15000 Vero cells were added per well. The plates were incubated at 37 °C and the wells showing c.p.e, were identified by microscopy on day 6. Virus was harvested from wells showing c.p.e, only in plates with 10 or fewer positive wells. In order to evaluate the purification efficiency of this single cloning step, a 1 : 1 mixture of type 1 (Mahoney) and type 3 (Sabin) polioviruses was analysed in the system. Twelve clones of the 15 studied were homogeneous, either type 1 or type 3. Forty-five poliovirus strains were isolated from six sewage water specimens using this method.
Microneutralization assay. Antigenic characteristics of the strains were assessed using a microneutralization assay as described by Huovilainen et al. (1987) , and a panel of type 3-specific MAbs (Ferguson et at., 1984; Minor et al., 1985) . Four of the MAbs were directed against site 1 (MAbs 175, 204, 472 and 495) , three were against site 2 (MAbs 882, 875 and 838) and one was against site 3 (879). The binding site of MAb 881 is on VP1, including amino acid 142 at least; that for 520 is not known but is likely to be site 1 because MAb 520 does not neutralize trypsincleaved poliovirus type 3 (M. Ferguson, unpublished data). MAb 842 is specific for the prototype strain of the Finnish outbreak but its binding site is not known.
Purification of virion RNA. Poliovirus strains grown in HEp-2 cells were purified essentially as described by Ukkonen et al. (1986) . Purified virus was diluted in 0.15 M-sodium acetate, 0'1 ~ SDS and extracted sequentially with phenol-chloroform-isoamyl alcohol (25:24:1), phenol, chloroform and ether. The RNA was then precipitated with ethanol, dried and dissolved in water at a concentration of approximately l ~tg/l-tl. Five units of RNase inhibitor (Boehringer Mannheim) per ~tg was added, and the specimens were frozen to -20 °C.
Primer extension sequencing. The viral RNA was sequenced directly by the dideoxynucleotide chain termination method of Sanger et al. (1977) . Synthetic oligonucleotide primers were purchased from the Department of Medical Chemistry, University of Helsinki, Helsinki, Finland. The hybridization mixture contained approximately 1 ~tg of template and 20 ng of primer. The mixture was heated at 90 °C for 1 min and then allowed to cool to room temperature. Then 2.5 ~tl of water and 0-5 ~tl of reverse transcription buffer (final concentration: 50 rnM-Tris-HC1 pH 8.3, 6 mM-MgCI2, 40 ml~-KCI) were added. One ~tl of this mixture was added to each of four tubes containing 1 ~tl of deoxynucleotide/dideoxynucleotide mixture, 8 ~tCi of [~-3sS]dATP (> 1000 ixCi/mmol, Amersham) and 5 units of reverse transcriptase (P & S Biochemicals, Liverpool, U.K.) in a final volume of 3 I*1. The A reaction contained 55.5 ~tM each of dCTP, dGTP, dTTP and 1.4 ~tM-ddATP. The C reaction contained 55-5 ~tM each of dGTP and dTTP, 11.1 btM-dCTP and 2.8 ~tM-ddCTP. The G reaction contained 55.5 btM each of dCTP and dTTP, 11.1 btM-dGTP and 2-8 ~tM-ddGTP. The T reaction contained 55-5 ~tM each of dCTP and dGTP, 11.1/.tM-dTTP and 2.8 rtM-ddTTP. Each reaction mixture was incubated at 37 °C for 30 min and then 1 p,l of a chase mixture containing 250 ~tM each of dATP, dCTP, dGTP and dTTP in 100 m~i-Tris-HCl pH 8.3 was added and incubation continued for 15 min. The reaction was stopped by adding 5 ~tl of formamide-dye mixture. The samples were heated for 2 rain at 90 °C before loading on a 6~ polyacrylamide buffer gradient gel (Biggin et al., 1983) . After electrophoresis, the gel was soaked for 10 min in 10~o acetic acid, 10~o methanol, and then dried at 80 °C under vacuum before autoradiography (Hyper film fl max, Amersham, 12 to 48 h).
RESULTS

Distribution of antigenic variants among P3/Finland/84-85 strains
One-hundred and twenty-eight isolates from 95 patients and healthy excretors were analysed using a microneutralization test and a set of five MAbs. According to the reaction pattern the strains were subdivided into four classes. Of them 46~ were class A, and not neutralized by any of the five MAbs (Table 1 ). The strains classified into the other subclasses were neutralized by one or more of the MAbs tested. Isolates belonging to each of the four subclasses (A, B, C, D) were also found in Turku (on the west coast of Finland). Fifty-five of the virus strains were tested using MAb 842 (specific for the prototype virus of this outbreak) and two strains, other than the prototype, were neutralized. One of these was class A and the other class D. Both were isolated from members of a single family, but not contacts of the excretor of the prototype strain.
Twenty of the 128 specimens were also tested with MAbs directed against antigenic sites 2 or 3 or against an unidentified site. Three strains were neutralized by each of the site 2-specific antibodies, none with the site 3-specific MAb and four strains with MAb 881 (Table 2) .
We have reported antigenic changes in sequential specimens from three persons . The 128 specimens examined included 26 additional sets of at least two sequential specimens. Ten out of 29 sets remained class A during the period examined, eight showed an t Vantaa is a city neighbouring Helsinki; Turku is located 165 km to the west; one strain from the 'others' came from Tampere 180 km north-west of Helsinki, the rest are from two regions in northern Finland. Table 1 antigenic change from A to B or C. Eleven were either group B, C or D from the beginning. One of the latter 11 sets of specimens showed an antigenic change 'forwards' from B to C and one 'backwards' from D to C between the first and second specimens.
The index case of the outbreak is the only example where we know the timing of collection of the specimens with respect to the course of infection. In this case the A to B change in antigenic phenotype was found as late as 1 month after the onset of clinical symptoms . Therefore we compared the intervals between the specimens in cases with persisting class A viruses with those in cases in which the A to B/C change was evident. The median times were similar (2 to 3 weeks). The relative proportion of class A strains among the faecal specimen isolates analysed decreased slightly towards the end of 1984 (Fig. 1) , but the very last P3/Finland strains isolated from sewage specimens in winter 1985 still had class A as a major component (Table 3) .
Amino acid substitutions at antigenic site 1
Amino acid substitutions in antigenic site 1 (as compared to those of the Sabin 3 strain) of a number of P3/Finland/84 strains have been described earlier (Magrath et al., 1986; Hughes et al., 1986) and genomic mutations resulting in amino acid substitutions associated with the antigenic shift from class A to B or C have also been reported previously Minor et al., 1987) . Fifteen other strains from six persons were partially sequenced and the results shown in Table 4 indicate that variation of the amino acid sequence could be demonstrated within antigenic classes A and B. Especially interesting was a strain (RK 888) with the class A antigenic phenotype which was resistant to all five antibodies used and had only an alanine to valine substitution at amino acid 99 when compared with the Sabin 3 strain used as immunogen.
An interesting set of observations concerns the amino acid sequences associated with the phenotype B (the virus neutralized by MAb 175). In the previously characterized isolates this A to B phenotypic change was associated with an amino acid substitution from asparagine to lysine at position 98 of VP1 . In this study strain AH 25897 was found to have the B phenotype and to differ from the typical class A sequence by having alanine instead of valine in position 99 and maintaining asparagine in position 98 of VP1. However, class A strain EM 25724 also had alanine at position 99 but differed from strain AH 25897 by the substitution of asparagine for aspartic acid at position 91. Some class D strains were neutralized, not only by MAbs 175 and 204 that neutralize class C, but also by 472 and 495, which are also considered to be antigenic site 1-specific. Surprisingly, no difference in the amino acid sequence at antigenic site 1 (or close to the site at the carboxy side) could be demonstrated between these different phenotypes of class D strains SE 811 and SE 25716. We have also shown that a plaque-purified virus strain of class D phenotype has an amino acid sequence at antigenic site 1 identical with that shown for class C isolates (data not shown).
A. HUOVILAINEN AND OTHERS
DISCUSSION
In this paper we have extended the documentation of antigenic and molecular variation of type 3 poliovirus isolates collected during a limited outbreak of poliomyelitis in Finland in 1984 to 1985. A total of 128 strains from human specimens were separated into four classes according to their reaction pattern with five neutralizing MAbs. The great variability of the strains was emphasized by the fact that one of the four classes comprised strains with several different reaction patterns. Furthermore, when some isolates were tested with five additional MAbs directed against different antigenic sites, even more variation could be seen.
A major phenotypic class (A) of isolates, not neutralized by any of the MAbs directed against site l, showed several different alternative amino acid sequences at antigenic site 1. Class B isolates that were neutralized by one of the tested MAbs also showed two alternative sequences at antigenic site 1, even though only a limited number of strains were analysed. On the other hand, class C and D strains showing different neutralization patterns with site 1-specific MAbs had identical amino acid sequences in antigenic site 1. This suggests that capsid regions other than amino acids 89 to 100 ofVP 1 contribute to the three-dimensional structure of antigenic site 1.
Replication of poliovirus RNA, like that of most RNA viruses, results in a relatively high rate of mutation. Consequently, the virus populations are, in fact, mixtures of several variants showing minor sequence differences from each other (Smith & Inglis, 1987; Steinhauer & Holland, 1987) . Under a suitable selection pressure, such as neutralizing antibodies in the body, a minor component in such a mixture that is capable of escaping the selection pressure can have an advantage and this may bring about a phenotypic change in the population. By using plaque purification we have shown previously that individual faecal specimens can indeed contain several antigenic variants of P3/Finland/84 strains . In principle, a hypothetical virus mixture containing a minority of variants resistant to a given MAb will show a false negative result in a standard neutralization assay, because of the overgrowth of the resistant variant strains. This possibility might compromise our results both on the distribution of the neutralization classes and on the relationship between the neutralization pattern and amino acid sequence. We have, however, previously documented the real existence of neutralization classes A, B and C by using plaque-purified virus strains . However the apparent proportion of class A strains in the present results may be overestimated, due to this potential source of error.
The amino acid sequences presented are deduced from the corresponding nucleotide sequences obtained by the primer extension sequencing method. This method shows the sequence of the majority component of a putative mixture of template RNA molecules. Hence, we cannot be sure whether all five different amino acid sequences for class A variants represent true alternatives or whether these specimens also contain, as a minority component, the 'classical' class A variant that is able to replicate in the presence of all the MAbs tested. Because of the existence of mixtures of different variants among the virus isolates we considered it unreasonable to attempt, before plaque purification, to find amino acid sequence correlations with the observed phenotypic variability at antigenic site 2.
Previously we have reported three sets of sequential specimens showing an antigenic change from the non-neutralizable class A variant to class B or C variants, that were neutralized by one or two MAbs raised against the Sabin 3 poliovirus. This unexpected direction of antigenic drift was partly explained by showing that the later isolates were sensitive to trypsin and also existed in the faecal specimens in the cleaved form . The trypsin cleavage site is known to be in VP1 at antigenic site 1 (Fricks et al., 1985; Icenogle et al., 1986) . The cleaved form of the virus cannot be neutralized by site 1-specific MAbs. Therefore, a mutation resulting in an amino acid sequence containing a trypsin cleavage site at antigenic site 1 is likely to provide the virus with a growth advantage in the intestinal mucosa. We have now tested 26 additional sets of sequential isolates. Since the time of infection at which the specimens were taken was not known, we cannot calculate the exact number of cases showing a similar antigenic change. However, since in most cases a class B or C virus either appeared or already existed in the first specimen, we may assume that this shift was a rather common phenomenon.
Furthermore, we can speculate that the interval between the times at which specimens were taken in those sets remaining class A may have been too short for an antigenic change to occur. Indeed, in the only case in which the timing was known (the index case of the outbreak; Huovilainen et al., 1987) the A to B shift took place as late as 1 month after the onset of the clinical symptoms.
Because of the frequency of the observed A to B/C shift one might assume that class A viruses might rapidly disappear from the population. The data do not support this expectation and therefore it is possible that class A viruses possess some properties making them superior to class B or C variants, for instance in the transmission of the infection to new hosts. Another possible explanation for the persistence of class A variants is that virus spreading in the high-hygiene host population was based on respiratory transmission. Poliovirus can be isolated from the respiratory mucosa during the first 1 to 2 weeks of infection only. This may be too short a period for the selection of new variants to take place, especially in the absence of the assumed growth advantage due to cleavage by intestinal trypsin.
In conclusion, we have shown in this paper that antigenic and molecular variation of the virulent type 3 poliovirus during the outbreak in Finland in 1984 to 1985 was extensive and involved several antigenic sites. Although it is obvious that cleavability by intestinal trypsin was a common selective factor in the present material it does not explain all the observed antigenic changes in the sequential specimens. Further work based on plaque-purified variants and sequencing of all known antigenic sites is in progress and hopefully will provide further light on the mechanisms of selection and enrichment of new virus variants in vivo.
